Author

D. C. Malherbe

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:host-pathogen & immune response· 4 Organism:mouse· 3 Assay:proteomics· 2 Organism:human· 1 Organism:non-human primate· 1

Frequent Co-Authors

A. Bukreyev· 3 shared C. Wirblich· 2 shared D. Kurup· 2 shared M. J. Schnell· 2 shared A. J. Ronk· 1 shared A. Ronk· 1 shared B. Kuo· 1 shared B. M. Doratt· 1 shared

Activity by Year

2020-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

A. Bukreyev

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

SARS-CoV-2 Vaccine Booster Elicits Robust Prolonged Maternal Antibody Responses and Passive Transfer Via The Placenta And Breastmilk

N. E. Marshall, M. B. Blanton, B. M. Doratt, D. C. Malherbe, M. Rincon, H. True, T. McDonald, C. Beauregard, R. Adatorwovor, I. Messaoudi

This study evaluates maternal SARS-CoV-2 vaccine antibody responses in circulation and breastmilk, showing that boosters increase antibody levels for passive transfer to newborns.

bioRxiv · Nov 29, 2022 · PreprintImmunology

A single dose of replication-competent VSV-vectored vaccine expressing SARS-CoV-2 S1 protects against virus replication in a hamster model of severe COVID-19

D. C. Malherbe, D. Kurup, C. Wirblich, A. J. Ronk, C. Mire, N. Kuzmina, N. Shaik, S. Periasamy, M. A. Hyde, J. M. Williams, P.-Y. Shi, M. J. Schnell, A. Bukreyev

A single dose of the VSV-vectored vaccine ConVac expressing SARS-CoV-2 S1 subunit protects hamsters from weight loss and viral replication after SARS-CoV-2 challenge.

bioRxiv · Jan 29, 2021Immunology

Inactivated rabies virus vectored SARS-CoV-2 vaccine prevents disease in a Syrian hamster model.

D. Kurup, D. C. Malherbe, C. Wirblich, R. Lambert, A. Ronk, L. Zabihi Diba, A. Bukreyev, M. J. Schnell

This study evaluates an inactivated rabies virus vectored SARS-CoV-2 vaccine in Syrian hamsters, showing protection against disease and viral replication.

bioRxiv · Jan 19, 2021Microbiology

A Novel SARS-CoV-2 Multitope Protein/Peptide Vaccine Candidate is Highly Immunogenic and Prevents Lung Infection in an AAV hACE2 Mouse Model and non-human primates

F. Guirakhoo, L. Kuo, J. Peng, J. H. Huang, B. Kuo, F. Lin, Y.-J. Liu, Z. Liu, G. Wu, S. Ding, K.-L. Hou, J. Cheng, V. Yang, H. Jiang, J. Wang, , C. Y. Wang

This paper describes a multitope protein-peptide vaccine candidate, UB-612, that is immunogenic and prevents lung infection in animal models, with ongoing clinical trials.

bioRxiv · Nov 30, 2020 · PreprintImmunology